Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG

por Ivens, Inge A., Banczyk, David, Gutberlet, Katrin, Jackman, Shawna, Vauléon, Stéphanie, Frisk, Anna-Lena
Publicado 2019

Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies

por Vauleon, Stephanie, Schutz, Katharina, Massonnet, Benoit, Gruben, Nanda, Manchester, Marianne, Buehler, Alessandra, Schick, Eginhard, Boak, Lauren, Hawellek, David J.
Publicado 2023

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

por Steurer, Michael, Montillo, Marco, Scarfò, Lydia, Mauro, Francesca R., Andel, Johannes, Wildner, Sophie, Trentin, Livio, Janssens, Ann, Burgstaller, Sonja, Frömming, Anna, Dümmler, Thomas, Riecke, Kai, Baumann, Matthias, Beyer, Diana, Vauléon, Stéphanie, Ghia, Paolo, Foà, Robin, Caligaris-Cappio, Federico, Gobbi, Marco
Publicado 2019